- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
迄今为止，共15家主力机构，持仓量总计9059.65万股，占流通A股12.39%
- 波段诊断：
-
技术面诊股
诊断结果：7.8技术面打败了88%的股票
技术面评分前10的股票
近期的平均成本为14.88元，股价在成本下方运行。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为14.88元，股价在成本下方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.88","date":1590292408,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2020.05.22","stock":"-2.45","trade":"-2.19","ind":"-2.22"},{"date":"2020.05.21","stock":"-2.95","trade":"-0.10","ind":"-0.94"},{"date":"2020.05.20","stock":"1.24","trade":"-0.83","ind":"-0.94"},{"date":"2020.05.19","stock":"-0.40","trade":"2.02","ind":"1.21"},{"date":"2020.05.18","stock":"4.12","trade":"0.30","ind":"-0.40"},{"date":"2020.05.15","stock":"5.04","trade":"-0.09","ind":"0.02"},{"date":"2020.05.14","stock":"1.04","trade":"-0.28","ind":"-1.02"},{"date":"2020.05.13","stock":"3.92","trade":"1.11","ind":"0.54"},{"date":"2020.05.12","stock":"0.80","trade":"1.28","ind":"0.42"},{"date":"2020.05.11","stock":"2.11","trade":"0.29","ind":"-0.29"},{"date":"2020.05.08","stock":"5.69","trade":"0.73","ind":"1.27"},{"date":"2020.05.07","stock":"10.00","trade":"0.23","ind":"-0.18"},{"date":"2020.05.06","stock":"0.89","trade":"1.16","ind":"1.51"},{"date":"2020.04.30","stock":"1.53","trade":"0.68","ind":"1.97"},{"date":"2020.04.29","stock":"-1.85","trade":"-1.47","ind":"0.12"},{"date":"2020.04.28","stock":"-2.14","trade":"-2.52","ind":"0.47"},{"date":"2020.04.27","stock":"0.74","trade":"0.51","ind":"0.28"},{"date":"2020.04.24","stock":"-5.00","trade":"-2.74","ind":"-1.33"},{"date":"2020.04.23","stock":"3.45","trade":"2.18","ind":"-0.50"},{"date":"2020.04.22","stock":"-1.37","trade":"1.16","ind":"1.05"},{"date":"2020.04.21","stock":"-2.55","trade":"-0.42","ind":"-1.08"}]
安科生物,深证成指,生物制品指数
压力支撑
该股压力位为14.81元，支撑位为14.27元。
[{"text":"\u538b\u529b\u4f4d","value":"14.81","date":1590076800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.27","date":1590076800,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.9资金面打败了50%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：05月25日 12:31
| 机构今日流向(万元) | -3991.69 | 机构5日流向(万元) | -4220.08 |
| 机构10日流向(万元) | -7391.40 | 机构20日流向(万元) | -19885.95 |
机构持仓
2020-03-31 与 2019-12-31 相比，主力机构持仓量减少6586.99万股，其中基金净增仓1家，主力净减仓145家，暂未发现中长期投资价值。
截止2020-03-31，共15家主力机构（基金10家，券商集合理财2家，一般法人3家），持仓量总计9059.65万股，占流通A股12.39%
其中，基金持仓与2019-12-31相比：
增仓：4家 ，增持 145.68万股
减仓：3家 ，减持 243.17万股
新出现在主力名单中：3家 ，持有1632.94万股
从主力名单中消失：148家 ，原持有7794.24万股
其中，基金持仓与2019-12-31相比：
增仓：4家 ，增持 145.68万股
减仓：3家 ，减持 243.17万股
新出现在主力名单中：3家 ，持有1632.94万股
从主力名单中消失：148家 ，原持有7794.24万股
消息面诊股
诊断结果：6.2消息面打败了81%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 安科生物10:30大单揭秘:主动大单卖出32910
2020-05-25 - 安科生物:2020-05-22融资融券余额减136
2020-05-25 - 安科生物(截止5月20日)股东人数为39500户
2020-05-22 - 14:30大单揭秘
2020-05-22 - 安科生物子公司免洗消毒护手产品获美国市场准入许可
2020-05-22 - 安科生物10:30大单揭秘:主动大单卖出40370
2020-05-22 - 安科生物:2020-05-21融资融券余额减261
2020-05-22 - 安科生物14:30大单揭秘:主动大单卖出82729
2020-05-21 - 安科生物10:30大单揭秘:主动大单卖出46653
2020-05-21 - 安科生物:2020-05-20融资融券余额减856
2020-05-21
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2020-04-08 |
| 利好 | 业绩预告 | 业绩预增 | 2020-04-08 |
| 利好 | 分红转增 | 10转3股派1.5元(含税) | 2020-04-08 |
| 一般消息 | 募资投向 | 公司购买资产 | 2020-04-08 |
| 一般消息 | 重大事项 | 关联交易 | 2020-04-08 |
| 一般消息 | 募资投向 | 2020-04-07 | |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2020-01-21 |
| 一般消息 | 分红转增 | 不分配不转增 | 2019-08-28 |
| 一般消息 | 重大事项 | 关联交易 | 2019-08-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2019-07-17 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：7.2行业面打败了97%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2020.05.22","price":"-2.22","value":"-2.19"},{"date":"2020.05.21","price":"-0.94","value":"-0.10"},{"date":"2020.05.20","price":"-0.94","value":"-0.83"},{"date":"2020.05.19","price":"1.21","value":"2.02"},{"date":"2020.05.18","price":"-0.40","value":"0.30"},{"date":"2020.05.15","price":"0.02","value":"-0.09"},{"date":"2020.05.14","price":"-1.02","value":"-0.28"},{"date":"2020.05.13","price":"0.54","value":"1.11"},{"date":"2020.05.12","price":"0.42","value":"1.28"},{"date":"2020.05.11","price":"-0.29","value":"0.29"},{"date":"2020.05.08","price":"1.27","value":"0.73"},{"date":"2020.05.07","price":"-0.18","value":"0.23"},{"date":"2020.05.06","price":"1.51","value":"1.16"},{"date":"2020.04.30","price":"1.97","value":"0.68"},{"date":"2020.04.29","price":"0.12","value":"-1.47"},{"date":"2020.04.28","price":"0.47","value":"-2.52"},{"date":"2020.04.27","price":"0.28","value":"0.51"},{"date":"2020.04.24","price":"-1.33","value":"-2.74"},{"date":"2020.04.23","price":"-0.50","value":"2.18"},{"date":"2020.04.22","price":"1.05","value":"1.16"},{"date":"2020.04.21","price":"-1.08","value":"-0.42"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 双林生物 | 42.78% | 25.66% | 6.7分 |
| 2 | 未名医药 | 31.16% | -9.77% | 5.5分 |
| 3 | 通化东宝 | 26.37% | 5.12% | 7.2分 |
| 4 | 安科生物 | 26.35% | -0.61% | 6.5分 |
| 5 | 特宝生物 | 21.84% | -2.67% | 6.2分 |
| 6 | 长春高新 | 19.10% | 1.37% | 6.5分 |
| 8 | 百奥泰 | 15.11% | -1.34% | 5.3分 |
| 10 | 华兰生物 | 10.44% | 11.67% | 6.5分 |
| 12 | 沃森生物 | 9.42% | -3.28% | 4.4分 |
| 14 | 天坛生物 | 3.86% | 3.25% | 6.5分 |
| 16 | 上海莱士 | 1.61% | -3.99% | 4.8分 |
| 18 | 智飞生物 | 1.45% | -3.27% | 5.1分 |
| 20 | 中源协和 | -0.63% | 10.68% | 6.5分 |
| 22 | 双鹭药业 | -4.72% | 3.23% | 5.4分 |
| 24 | 常山药业 | -5.08% | -5.42% | 4.2分 |
| 26 | 万泽股份 | -7.08% | -1.98% | 5.4分 |
| 28 | 东宝生物 | -12.45% | -5.38% | 4.1分 |
| 30 | 复星医药 | -17.14% | -4.92% | 4.3分 |
| 32 | 康辰药业 | -17.79% | -2.82% | 4.1分 |
| 34 | 四环生物 | -19.05% | -6.90% | 4.5分 |
| 36 | 金花股份 | -25.88% | -9.20% | 4.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2020-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/103 ， 13/103。
[{"date":"2020-03-31","value":"3.05","vol":"1.25"},{"date":"2019-12-31","value":"5.47","vol":"18.73"},{"date":"2019-09-30","value":"10.97","vol":"5.44"},{"date":"2019-06-30","value":"6.55","vol":"3.31"},{"date":"2019-03-31","value":"2.90","vol":"0.96"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
3.05 | 5.47 | 10.97 | 6.55 | 2.90 |
| 行业(%) | 1.25 | 18.73 | 5.44 | 3.31 | 0.96 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"79.72","vol":"64.26"},{"date":"2019-12-31","value":"78.03","vol":"66.09"},{"date":"2019-09-30","value":"79.82","vol":"66.62"},{"date":"2019-06-30","value":"79.68","vol":"63.96"},{"date":"2019-03-31","value":"79.30","vol":"63.78"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
79.72 | 78.03 | 79.82 | 79.68 | 79.30 |
| 行业(%) | 64.26 | 66.09 | 66.62 | 63.96 | 63.78 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 18/103 ， 10/103。
[{"date":"2020-03-31","value":"-9.21","vol":"-7.56"},{"date":"2019-12-31","value":"17.17","vol":"14.62"},{"date":"2019-09-30","value":"14.24","vol":"16.65"},{"date":"2019-06-30","value":"21.71","vol":"13.75"},{"date":"2019-03-31","value":"24.16","vol":"15.08"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-9.21 | 17.17 | 14.24 | 21.71 | 24.16 |
| 行业(%) | -7.56 | 14.62 | 16.65 | 13.75 | 15.08 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"22.68","vol":"93.83"},{"date":"2019-12-31","value":"-52.71","vol":"36.26"},{"date":"2019-09-30","value":"10.95","vol":"265.92"},{"date":"2019-06-30","value":"13.15","vol":"-1.25"},{"date":"2019-03-31","value":"11.41","vol":"-2.76"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
22.68 | -52.71 | 10.95 | 13.15 | 11.41 |
| 行业(%) | 93.83 | 36.26 | 265.92 | -1.25 | -2.76 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 11/103 ， 7/103。
[{"date":"2020-03-31","value":"0.10","vol":"0.08"},{"date":"2019-12-31","value":"0.60","vol":"0.45"},{"date":"2019-09-30","value":"0.40","vol":"0.33"},{"date":"2019-06-30","value":"0.27","vol":"0.21"},{"date":"2019-03-31","value":"0.12","vol":"0.09"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.60 | 0.40 | 0.27 | 0.12 |
| 行业(次) | 0.08 | 0.45 | 0.33 | 0.21 | 0.09 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.48","vol":"0.32"},{"date":"2019-12-31","value":"3.41","vol":"1.77"},{"date":"2019-09-30","value":"2.04","vol":"1.27"},{"date":"2019-06-30","value":"1.41","vol":"0.86"},{"date":"2019-03-31","value":"0.72","vol":"0.38"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.48 | 3.41 | 2.04 | 1.41 | 0.72 |
| 行业(次) | 0.32 | 1.77 | 1.27 | 0.86 | 0.38 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2020-03-31","value":"18.01","vol":"-19.89"},{"date":"2019-12-31","value":"29.38","vol":"28.09"},{"date":"2019-09-30","value":"16.88","vol":"-483.71"},{"date":"2019-06-30","value":"13.79","vol":"16.14"},{"date":"2019-03-31","value":"2.69","vol":"2.31"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 18.01 | 29.38 | 16.88 | 13.79 | 2.69 |
| 行业 | -19.89 | 28.09 | -483.71 | 16.14 | 2.31 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"","vol":"0.00"},{"date":"2019-12-31","value":"2.80","vol":"3.01"},{"date":"2019-09-30","value":"","vol":"0.03"},{"date":"2019-06-30","value":"3.09","vol":"3.15"},{"date":"2019-03-31","value":"","vol":"0.26"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.80 | - | 3.09 | - |
| 行业 | 0.00 | 3.01 | 0.03 | 3.15 | 0.26 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 23/103 ， 22/103。
[{"date":"2020-03-31","value":"3.97","vol":"5.47"},{"date":"2019-12-31","value":"3.56","vol":"4.79"},{"date":"2019-09-30","value":"4.82","vol":"4.92"},{"date":"2019-06-30","value":"3.26","vol":"4.58"},{"date":"2019-03-31","value":"3.48","vol":"4.79"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.97 | 3.56 | 4.82 | 3.26 | 3.48 |
| 行业 | 5.47 | 4.79 | 4.92 | 4.58 | 4.79 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"3.52","vol":"4.08"},{"date":"2019-12-31","value":"3.21","vol":"3.49"},{"date":"2019-09-30","value":"3.56","vol":"3.05"},{"date":"2019-06-30","value":"2.58","vol":"2.89"},{"date":"2019-03-31","value":"2.78","vol":"3.03"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
3.52 | 3.21 | 3.56 | 2.58 | 2.78 |
| 行业 | 4.08 | 3.49 | 3.05 | 2.89 | 3.03 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 25/103 ， 25/103。
[{"date":"2020-03-31","value":"14.95","vol":"24.69"},{"date":"2019-12-31","value":"16.31","vol":"25.45"},{"date":"2019-09-30","value":"12.21","vol":"25.95"},{"date":"2019-06-30","value":"16.57","vol":"26.89"},{"date":"2019-03-31","value":"16.54","vol":"26.43"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
14.95 | 16.31 | 12.21 | 16.57 | 16.54 |
| 行业(%) | 24.69 | 25.45 | 25.95 | 26.89 | 26.43 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.18","vol":"0.59"},{"date":"2019-12-31","value":"0.20","vol":"0.62"},{"date":"2019-09-30","value":"0.14","vol":"0.39"},{"date":"2019-06-30","value":"0.20","vol":"0.41"},{"date":"2019-03-31","value":"0.20","vol":"0.42"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.18 | 0.20 | 0.14 | 0.20 | 0.20 |
| 行业(%) | 0.59 | 0.62 | 0.39 | 0.41 | 0.42 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 天风证券 | 2020-05-07 | 增持 | |
| 国盛证券 | 2020-05-06 | 买入 | |
| 西南证券 | 2020-04-29 | 买入 | 买入 |
| 中泰证券 | 2020-04-29 | 增持 | 增持 |
| 中信建投 | 2020-04-29 | 买入 | 买入 |
| 方正证券 | 2020-04-28 | 买入 | 买入 |
机构预测
机构预测该股2020年每股收益与前一年相同，长期投资价值一般。
[{"date":"2016","yellowRectValue":"1.97","blueLineValue":"","type":""},{"date":"2017","yellowRectValue":"2.78","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"2.63","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"1.24","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"4.17","blueLineValue":"0.31","type":"YC"}]